Progression to overt nephropathy in type 2 diabetes - The Casale Monferrato study

被引:100
作者
Bruno, G
Merletti, F
Biggeri, A
Bargero, G
Ferrero, S
Pagano, G
Perin, PC
机构
[1] Univ Turin, Dept Internal Med, I-10126 Turin, Italy
[2] Univ Turin, Canc Epidemiol Unit, I-10126 Turin, Italy
[3] Univ Florence, Dept Stat G Parenti, Florence, Italy
[4] Santo Spirito Hosp, Alessandria, Italy
关键词
D O I
10.2337/diacare.26.7.2150
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE - The first sign of diabetic nephropathy is microalbuminuria, but its predictive role of progression to overt nephropathy in type 2 diabetes has not yet been clarified. The aims of this study were to assess during 7 years of follow-up the incidence rate of overt nephropathy and the predictive role of microalbuminuria and other baseline variables (blood pressure, lipids, fibrinogen, uric acid, smoking, and HbA(1c) cumulative average during follow-up). RESEARCH DESIGN AND METHODS - A prospective population-based study was performed in Casale Monferrato, Italy, including 1,255 type 2 diabetic patients recruited at baseline (1991-1992), 765 with normoalbuminuria (albumin excretion rate [AER] <20 mug/min) and 488 with microalbuminuria (AER 20-200 mug/min). All measurements were centralized. A nested case-control study,within the cohort, was performed, selecting four control subjects, frequency matched for age and attained individual. time of follow-up with each case. Conditional regression analysis was performed to assess variables independently associated with risk of progression to overt nephropathy. RESULTS - Of 1,253 total patients, 1,103 (88.0%) were included in the follow-up examination.(median 5.33 years); their age and duration of disease at baseline were 68.4 +/- 10.5 years and 10.4 +/- 6.6 years,. respectively. Cases of overt nephropathy were 202, giving an incidence rate of 37.0/1,000 person-years (95% CI 32.3-42.6). In conditional logistic regression analyses, microalbuminuria provided a 42% increased risk with respect to normoalbuminuria (95% CI 0.98-2.06), independently of duration of diabetes, hypertension, and systolic blood pressure. Other variables independently associated with progression to overt nephropathy were HbA(1c) cumulative average (P = 0.002), apolipoprotein B (P = 0.013), fibrinogen (P = 0.02), and HDL cholesterol (P = 0.03). CONCLUSIONS - Of type 2 diabetic patients, 3.7% progress every year to overt nephropathy. microalbuminuria is associated with a 42% increased risk of progression to overt nephropathy. Other independent predictors are HbA(1c), HDL cholesterol, apolipoprotein B, and fibrinogen.
引用
收藏
页码:2150 / 2155
页数:6
相关论文
共 29 条
[1]
Bonnet F, 2000, DIABETES METAB, V26, P254
[2]
Bruno G, 1998, DIABETIC MED, V15, P304, DOI 10.1002/(SICI)1096-9136(199804)15:4<304::AID-DIA571>3.0.CO
[3]
2-D
[4]
Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus [J].
Bruno, G ;
CavalloPerin, P ;
Bargero, G ;
Borra, M ;
DErrico, N ;
Pagano, G .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (08) :653-657
[5]
NATIONAL DIABETES PROGRAMS [J].
BRUNO, G ;
LAPORTE, RE ;
MERLETTI, F ;
BIGGERI, A ;
MCCARTY, D ;
PAGANO, G .
DIABETES CARE, 1994, 17 (06) :548-556
[6]
A POPULATION-BASED PREVALENCE SURVEY OF KNOWN DIABETES-MELLITUS IN NORTHERN ITALY BASED UPON MULTIPLE INDEPENDENT SOURCES OF ASCERTAINMENT [J].
BRUNO, G ;
BARGERO, G ;
VUOLO, A ;
PISU, E ;
PAGANO, G .
DIABETOLOGIA, 1992, 35 (09) :851-856
[7]
Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects [J].
Bruno, G ;
CavalloPerin, P ;
Bargero, G ;
Borra, M ;
Calvi, V ;
DErrico, N ;
Deambrogio, P ;
Pagano, G .
DIABETES CARE, 1996, 19 (01) :43-47
[8]
Cardiovascular risk profile of type 2 diabetic patients cared for by general practitioners or at a diabetes clinic: A population-based study [J].
Bruno, G ;
Cavallo-Perin, P ;
Bargero, G ;
Borra, M ;
D'Errico, N ;
Macchia, G ;
Veglio, M ;
Pagano, G .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (05) :413-417
[9]
The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient? [J].
Caramori, ML ;
Fioretto, P ;
Mauer, M .
DIABETES, 2000, 49 (09) :1399-1408
[10]
THE RELATIONSHIP BETWEEN SMOKING AND MICROVASCULAR COMPLICATIONS IN THE EURODIAB IDDM COMPLICATIONS STUDY [J].
CHATURVEDI, N ;
STEPHENSON, JM ;
FULLER, JH ;
KARAMANOS, B ;
TOUNTAS, C ;
KOFINIS, A ;
PETROU, K ;
KATSILAMBROS, N ;
GIORGINO, R ;
CIGNARELLI, M ;
DECICCO, ML ;
RAMUNNI, I ;
IONESCUTIRGOVISTE, C ;
IOSIF, CM ;
PITEI, D ;
BULIGESCU, S ;
TAMAS, G ;
KERENYI, Z ;
AHMED, AM ;
TOTH, J ;
KEMPLER, P ;
MUNTONI, S ;
SONGINI, M ;
STABILINI, M ;
FOSSARELLO, M ;
PINTUS, S ;
MUNTONI, S ;
FERRISS, JB ;
CRONIN, CC ;
WHYTE, AE ;
CLEARY, PE ;
TOELLER, M ;
KLISCHAN, A ;
FORST, T ;
GRIES, FA ;
WAGENER, W ;
ROTTIERS, RR ;
PRIEM, H ;
EBELING, P ;
SINISALO, M ;
KOIVISTO, VA ;
IDZIORWALUS, B ;
SOLNICA, B ;
SZOPINSKACIBA, L ;
SOLNICA, K ;
KRANS, HMJ ;
LEMKES, HHPJ ;
JANSEN, JJ ;
BRACHTER, J ;
NUNESCORREA, J .
DIABETES CARE, 1995, 18 (06) :785-792